The Global Alzheimer's Initiative Now Act authorizes the United States to officially participate in and contribute funding to the Davos Alzheimer's Collaborative, an international public-private partnership working to develop treatments and diagnostics for Alzheimer's disease and dementia worldwide. The bill establishes that U.S. contributions can come from existing foreign aid budgets and sets a funding cap limiting American contributions to no more than 33 percent of the collaborative's total funding through 2029, ensuring other countries and private sources share the financial burden. The legislation is motivated by the growing global health crisis of Alzheimer's disease, which currently affects nearly 60 million people worldwide and is projected to reach 150 million by 2050, particularly in low- and middle-income countries where over 70 percent of cases exist. The bill requires the President to submit annual reports to Congress detailing U.S. financial contributions, governance participation, and how the initiative supports American global health strategy. A designated U.S. representative from the relevant federal agency will serve on the collaborative's advisory council and potentially its board while coordinating with USAID, the State Department, and the Department of Health and Human Services.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.